Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Boogaerts

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Blut|June 1, 1989
Progress in the therapy of myelodysplastic syndromesM A Boogaerts
Mycoses|January 1, 1989
Risks involved in selective decontamination in immunocompromised patientsM A Boogaerts
Current Opinion in Hematology|November 14, 1998
Stem cell transplantation and intensified cytotoxic treatment for myelodysplasiaM A Boogaerts
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Anti-infective strategies in neutropeniaM A Boogaerts
International Journal of Antimicrobial Agents|February 1, 1996
Antifungal prophylaxis in neutropenic patientsM A Boogaerts
British Journal of Haematology|July 1, 1986
The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesG Tricot, M A Boogaerts
Acta Clinica Belgica|August 14, 1998
Anti-infective strategies in neutropenic patientsJ Maertens, M A Boogaerts
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factorM A Boogaerts, H Demuynck
Current Pharmaceutical Design|January 19, 2000
Fungal cell wall inhibitors: emphasis on clinical aspectsJ A Maertens, M A Boogaerts
Current Opinion in Infectious Diseases|October 13, 2006
Antifungal prophylaxis in neutropeniaJ A Maertens, M A Boogaerts
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Blut|June 1, 1989
Progress in the therapy of myelodysplastic syndromesM A Boogaerts
Mycoses|January 1, 1989
Risks involved in selective decontamination in immunocompromised patientsM A Boogaerts
Current Opinion in Hematology|November 14, 1998
Stem cell transplantation and intensified cytotoxic treatment for myelodysplasiaM A Boogaerts
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Anti-infective strategies in neutropeniaM A Boogaerts
International Journal of Antimicrobial Agents|February 1, 1996
Antifungal prophylaxis in neutropenic patientsM A Boogaerts
British Journal of Haematology|July 1, 1986
The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesG Tricot, M A Boogaerts
Acta Clinica Belgica|August 14, 1998
Anti-infective strategies in neutropenic patientsJ Maertens, M A Boogaerts
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factorM A Boogaerts, H Demuynck
Current Pharmaceutical Design|January 19, 2000
Fungal cell wall inhibitors: emphasis on clinical aspectsJ A Maertens, M A Boogaerts
Current Opinion in Infectious Diseases|October 13, 2006
Antifungal prophylaxis in neutropeniaJ A Maertens, M A Boogaerts
Pageof 10